On Friday, KeyCorp (NYSE:KEY)’s shares inclined 3.04% to $13.39.
KEY has 82.80% institutional ownership while its EPS ratio was 1.07. The company has 835.37 million shares outstanding while market capitalization of the company was $11.19 billion. Price to book ratio was 1.07. Net profit margin of the company was 35.70%. Stock volatility for the month was booked as 1.83% while for the week was recorded as 2.58%.
The mean estimate for the short term price target for KeyCorp (NYSE:KEY) stands at $14.90 according to 26 Analysts. The higher price target estimate for the stock has been calculated at $17.00 while the lower price target estimate is at $13.00.
Analysts mean recommendation for the stock is 2.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
KeyCorp is a bank holding company. The Bank operates through its subsidiary, KeyBank National Association, which is engaged in providing banking services. Through KeyBank and other subsidiaries, the Bank provides a range of retail and commercial banking, commercial leasing, investment management, consumer finance, commercial mortgage servicing and special servicing, and investment banking products and services. The Bank provides these services to individual, corporate and institutional clients .
Regions Financial Corp (NYSE:RF)’s shares gained 4.06% to $10.12.
RF has the market capitalization of $13.22 billion. The stock has P/B ratio of 0.83 while EPS was $0.69. Institutional ownership of the company was 75.50% while 1.31 billion shares were outstanding. Net profit margin of the Company was 25.60% while. Share of the company moved above its SMA 50 with 9.57%. ROE ratio was 5.70% while ROI was 14.20%.
The mean estimate for the short term price target for Regions Financial Corp (NYSE:RF) stands at $10.85 according to 31 Analysts. The higher price target estimate for the stock has been calculated at $12.50 while the lower price target estimate is at $10.00.
Analysts mean recommendation for the stock is 2.20. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Regions Financial Corporation is a financial holding company. The Company conducts its banking operations through Regions Bank, an Alabama state-chartered commercial bank, which is a member of the Federal Reserve System. The Company carries out its business in three segments: Corporate Bank, Consumer Bank and Wealth Management.
At the end of Friday’s trade, ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)‘s shares surged 6.20% to $13.70.
ZIOP Its past 5-day performance at 20.28%. So far in 2015, the company has a year-to-date performance of 170.22%. The stock, as of last close, traded 352.15% up from its 52 week low and was -4.86% below its 52 week high. Its latest closing price was 26.95% above the SMA200 while the distance from SMA 50 and SMA 20 was 27.89% and 20.34% respectively.
The mean estimate for the short term price target for ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) stands at $15.50 according to 2 Analysts. The higher price target estimate for the stock has been calculated at $21.00 while the lower price target estimate is at $10.00.
Analysts mean recommendation for the stock is 2.60. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company. The Company is engaged in the acquisition, development and commercialization of a portfolio of cancer therapies through synthetic biology. The Company’s pipeline includes a number of cell-based therapeutics in both clinical and preclinical testing which are focused on hematologic and solid tumor malignancies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.